VAG-4602: Vaginal estradiol tablets (Vagifem®) and endometrial cancer risk in the treatment of postmenopausal vaginal atrophy: A register-based cohort study in postmenopausal women

First published 17/01/2022

Last updated 15/01/2025

EU PAS number:

EUPAS44951

Study

Finalised

Documents

Study protocol

Initial protocol

VAG-4602 16-1-01 protocol eu-pas-reg redacted

English (616.05 KB - PDF)View document

Study results

Study report

4602 nsr eu-pas-reg redacted.pdf

English (1.28 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs